Earnings History Data for ACELYRIN, INC. (SLRN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ACELYRIN, INC.
Acelyrin Inc. is a clinical biopharma company. It focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep. Acelyrin Inc. is based in Agoura Hills, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | SLRN | ACELYRIN, INC. | 604.84 | -0.49 | -0.84 | -0.87 | Acelyrin GAAP EPS of -$0.49 beats by $0.32 [11/13/2024 4:05 PM] |
5.16 | -0.83 (-13.80%) |
6.23 | 0.25 (4.18%) |
3.36 - 9.25 | 1,135,831 | 400,000 | 20,020 | ||
| 13-08-2024 | AH | SLRN | ACELYRIN, INC. | 492.00 | -0.86 | -0.78 | 0.00 | Acelyrin GAAP EPS of -$0.86 misses by $0.17 [8/13/2024 4:26 PM] |
4.08 | -0.68 (-14.39%) |
4.25 | -0.51 (-10.71%) |
3.36 - 29.88 | 4,868,076 | 1,250,000 | 93,575 | ||
| 28-03-2024 | AH | SLRN | ACELYRIN, INC. | 647.00 | -0.75 | -1.00 | 0.00 | Acelyrin GAAP EPS of -$5.43 [3/28/2024 5:01 PM] |
6.75 | 0.0 (0.00%) |
6.88 | 0.13 (1.93%) |
5.70 - 29.88 | 791,165 | 2,240,000 | 13,781 | ||
| 07-11-2023 | AH | SLRN | ACELYRIN, INC. | 887.81 | -0.87 | -0.47 | 0.00 | Acelyrin GAAP EPS of -$0.87 [11/7/2023 4:51 PM] |
8.47 | -0.73 (-7.93%) |
8.96 | -0.24 (-2.61%) |
8.19 - 29.88 | 1,413,338 | 1,100,000 | 14,338 | ||
| 14-08-2023 | AH | SLRN | ACELYRIN, INC. | 2,420 | -0.56 | -0.81 | 0.00 | Acelyrin GAAP EPS of -$0.40 beats by $0.22 [8/15/2023 10:41 AM] |
27.00 | 1.95 (7.78%) |
23.85 | -1.20 (-4.79%) |
16.60 - 28.12 | 1,467,632 | 860,000 | 840 | ||
| 15-06-2023 | AH | After the close (Jun 15) |
SLRN | ACELYRIN, INC. | 1,748 | -2.11 | -0.88 | 0.00 | Acelyrin GAAP EPS of -$8.61 [6/15/2023 4:21 PM] |
19.57 | 0.24 (1.24%) |
19.33 | 0.0 (0.00%) |
16.60 - 25.84 | 523,250 | 380,000 | 2,148 | |